Carasent

Q3 2025 highlights

• Net sales amounted to MSEK 82.2 (64.5), corresponding to a net sales growth of 27%.
• Organic growth was 13%, while net acquisitions and divestments in the last twelve months accounted for MSEK 9.3 or 14 percentage points of growth.
• EBITDA amounted to MSEK 23.6 (6.3), corresponding to an EBITDA margin of 29% (10%).
• Adjusted EBITDA margin was 29% (19%).
• Operating result, EBIT, amounted to MSEK 7.2 (-8.5).
• EBITDAC margin was 15% (-3%).
• Cash flow from operating activities amounted to MSEK 2.5 (-5.5).
• Net Income amounted to MSEK 14.1 (-2-0).
• Earnings per share, before and after dilution, amounted to SEK 0.2 (-0.03).

YTD Q3 2025 highlights

• Net sales amounted to MSEK 250.3 (196.5), corresponding to net sales growth of 27%.
• Organic growth was 14%, while net acquisitions and divestments in the last twelve months accounted for MSEK 28.1 or 14 percentage points of growth.
• EBITDA amounted to MSEK 49.6 (20.3), corresponding to an EBITDA margin of 20% (10%).
• Adjusted EBITDA margin was 20% (16%).
• Operating result, EBIT, amounted to MSEK 1.7 (-30.4).
• EBITDAC margin was 8% (-7%).
• Cash flow from operating activities amounted to MSEK 19.8 (21.4).
• Net income amounted to MSEK 5.6 (-18.0).
• Earnings per share, before and after dilution, amounted to SEK 0.08 (-0.25).

The results will be presented as a webcast at 8:00 CET today. If you wish to participate via webcast please use the link below.
https://events.inderes.com/carasent/q3-report-2025

For further details please contact:
Daniel Öhman, CEO Tel: +46 70-855 37 07, or
Svein Martin Bjørnstad, CFO Tel: +47 979 69 493